An amplified fragment length polymorphism (AFLP) method was applied to 129 strains representing 24 different Clostridium species, with special emphasis on pathogenic clostridia of medical or veterinary interest, to assess the potential of AFLP for identification of clostridia. In addition, the ability of the same AFLP protocol to type clostridia at the strain level was assessed by focusing on Clostridium perfringens strains. All strains were typeable by AFLP, so the method seemed to overcome the problem of extracellular DNase production. AFLP differentiated all Clostridium species tested, except for Clostridium ramosum and Clostridium limosum, which clustered together with a 45% similarity level. Other Clostridium species were divided into species-specific clusters or occupied separate positions. Wide genetic diversity was observed among Clostridium botulinum strains, which were divided into seven species-specific clusters. The same AFLP protocol was also suitable for typing C. perfringens at the strain level. A total of 29 different AFLP types were identified for 37 strains of C. perfringens; strains initially originating from the same isolate showed identical fingerprinting patterns and were distinguished from unrelated strains. AFLP proved to be a highly reproducible, easy-toperform, and relatively fast method which enables high throughput of samples and can serve in the generation of identification libraries. These results indicate that the AFLP method provides a promising tool for the identification and characterization of Clostridium species.The genus Clostridium is a heterogeneous group of bacteria which currently consists of 181 described species. Clostridia are widely distributed in the environment as well as in the intestinal tract of humans and of many animals. Several Clostridium species are pathogenic to humans, domestic animals, or wildlife and are responsible for well-known clostridial diseases such as tetanus, gas gangrene, botulism, pseudomembranous colitis, and food-borne illness (10). In addition, clostridia can be involved in a variety of human infections, such as cholecystitis, pneumonia, bacteremia, empyema, and abscesses, and can thus be isolated from various clinical specimens. However, many of the isolates can be occasional contaminants, or nonpathogenic clostridia, and may not be involved in the disease process. Therefore, the reliable identification of clostridia, isolated from clinical specimens, is important. In addition, a link must be established between isolated clostridia and pathological changes.Despite the clinical significance of clostridia, reliable, practical, and fast identification methods are few. Although simple tests can serve to identify most commonly isolated Clostridium species, the identification of other clostridia by conventional biochemical testing and gas-liquid chromatography is still laborious, expensive, and time-consuming. Furthermore, several commercial identification systems for anaerobic bacteria have failed to accurately identify Clostridium species (23,...